PerkinElmer
check quantity

OsteoSense 800 Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications. 

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Part Number List Price Your Price Quantity
NEV11105 572.00 USD
Buy Now

You successfully added item(s) to your cart

Overview

OsteoSense® 800 is a targeted fluorescent in vivo bisphosphonate imaging agent. OsteoSense 800 images areas of microcalcifications and bone remodeling and enables imaging of bone growth and resorption. OsteoSense 800 fluorescent imaging agent at a wavelenth at 800 nm, can be used to measure the effects of therapeutic stimulation of bone growth. This agent can also be used to characterize bone remodeling associated with animal models of arthritis. OsteoSense 800 enables in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.

Disclaimer:  For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name OsteoSense
Quantity in a Package Amount 1.0 Units
Shipping Condition Ambient
Therapeutic Area Atherosclerosis, Arthritis, Oncology/Cancer
Unit Size 1 Vial (10 doses)
Wave Length 800 nm

Tools

Resources, Events & More

All (7)
Resource Type File Name File Format
Brochure FMT Fluorescence Tomography in vivo Imaging Systems PDF  1 MB
Brochure In Vivo Imaging Agents Brochure PDF  2 MB
Technical Note OsteoSense 800 (Protocol) PDF  215 KB
Technical Note OsteoSense® 800 (Data Sheet) PDF  176 KB
Poster Imaging of Cathepsin K activity in rodent models of bone turnover and soft tissue calcification PDF  966 KB
Citations Library View peer reviewed publications using PerkinElmer's In Vivo Imaging Reagents Link
Webinars View our complete list of in vivo webinars available on demand Link